Work

Randomized phase II trial of sorafenib alone or in combination with carboplatin/paclitaxel in women with recurrent platinum sensitive epithelial ovarian, peritoneal, or fallopian tube cancer

Year: 2014

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-014-0078-5

Authors: Anita Schwandt, Vivian E. von Gruenigen, Robert M. Wenham, Heidi Frasure, Susan Eaton, Nancy Fusco, Pingfu Fu, John J. Wright, Afshin Dowlati, Steven Waggoner

Institutions: Case Western Reserve University, Summa Akron City Hospital, Moffitt Cancer Center, University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, National Cancer Institute, University Hospitals Seidman Cancer Center

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis, G4811386736

OpenAlex ID: W2011264584

FWCI: 4.104

Cites: 29

Cited by: 28

Related to: 10